Resources:

Find resources by:

Sort by:

Date Resource A-Z Random

Resources from the last:

Box size:

Filer text box:

Topic familiarity:

Grid Layout:

Collections that use this topic:

Collection topics:

Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid

Neuroendocrinology Somatostatin

Pituitary Brain Tumours Hypothalamus Kisspeptin ACTH TSH Cushing's NETs Paraganglioma Vasopressin Neuroendocrine Growth Somatostatin

Resource not read: Query News

Resource not read: Query Programmes

Resource not read: Query You and Your Hormones

SEX-SPECIFIC ISLET HORMONE RELEASE BY GHSR1A ANTAGONIST LEAP2

177Lu-Dotatate in advanced midgut NETs

Long term pegvisomant for acromegaly

HYPOTHALAMIC LINKS BETWEEN GROWTH AND ENERGY BALANCE

SECOND-LINE TREATMENTS FOR GH- VERSUS GH&PRL-SECRETING TUMOURS IN ACROMEGALY

Three new endocrine drugs approved

MOLECULAR (FUNCTIONAL) IMAGING FOR PITUITARY ADENOMAS

Time for tea? Encouraging a support network among patients with acromegaly

THE BIRTH OF ENDOCRINOLOGY AND NEUROENDOCRINOLOGY

TECHNOLOGICAL ADVANCES IN NEUROENDOCRINE TUMOUR RESEARCH

Endocrine disorders with 'cat-titude'

Endocrinologist 154 Web Version

Endocrinologist 146 Web

Endocrinologist 144 Web

Endocrinologist 153 Web Version

The Endocrinologist 118 Web.pdf

Endocrinologist 123 Web

The Endocrinologist 117 Web.pdf

The Endocrinologist 114 Web.pdf

Endocrinologist 122 FINAL Web.pdf

Endocrinologist 138 Web

The Endocrinologist 115 Web FINAL.pdf

Endocrinologist 141 Web

Distribution of somatostatin receptors in the hypothalamus of control and prenatally androgenised ewes

Somatostatin analogs in the treatment of acromegaly: single centre experience

High-dose treatment with somatostatin analogues in neuroendocrine tumours

Role of filamin A in dopamine and somatostatin receptor targeting in the pituitary

mRNA expression of somatostatin receptor subtypes in pheochromocytomas/paragangliomas

Expression of somatostatin receptors in proliferating and quiescent endothelial cells

A novel mechanism of effect for somatostatin analogues: the role of AIP

Treatment of active acromegaly with the somatostatin analogue lanreotide SR

Unveiling the therapeutic role of somatostatin and cortistatin in prostate cancer

Postoperative use of somatostatin analogs and mortality in patients with acromegaly

Presence and pathophysiological role of sst5TMD4, an aberrant spliced variant of the somatostatin receptor subtype 5, in human high-grade astrocytomas

The effectiveness of yttrium90/lutetium177-labeled somatostatin analogues treatment in functional pNETs

Prevalence of cholelithiasis in somatostatin analogues treated Acromegaly patients

Somatostatin receptor expression of gastroenteropancreatic neuroendocrine tumors: a comprehensive analysis of expression in the era of somatostatin receptor PET imaging

Somatostatin analogues in the treatment of acromegaly: correlation between somatostatin receptor subtype expression levels and clinical response

Detection of somatostatin receptors in aggressive non-functioning pituitary adenomas and effects of somatostatin analogs therapy in these tumors

Secretion of Somatostatin and Growth Hormone (GH) in Various Forms of Hereditary Pathology

The role of immunohistochemical assessment of somatostatin receptor expression in case of patients with well differentiated neuroendocrine neoplasms with symptoms of carcinoid syndrome and negative somatostatin receptor imaging

Potential therapeutic role of somatostatin and cortistatin in prostate cancer

Somatostatin receptor splicing variant SST5TMD4 overexpression in glioblastoma is associated to poor survival, increased aggressiveness features and somatostatin analogs resistance

Somatostatin Analogue Treatment of a Persistant TSH-Secreting Adenoma: a report of case

Parenteral somatostatin analogues: a focus on injection site adverse reactions

Lesson learnt: severe skin reaction to somatostatin analogue injections

Effect of a modulation of somatostatin release on TSH secretion in healthy volunteers

Expression of somatostatin and dopamine receptors in neuroendocrine tumors: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores

BIM-23244, a somatostatin analogue with high affinity for somatostatin receptors 2 and 5, inhibits endothelial proliferation <i>in vitro</i>

Prolonged remission of acromegaly after cessation of somatostatin analogue treatment

Endometriotic cell proliferation and survival are inhibited by somatostatin analogues and GHRH antagonists

Glucagon-like peptide-1 stimulates insulin secretion and then somatostatin secretion in rat islets

Somatostatin analog therapy in advanced sporadic medullary thyroid carcinoma: a case report

Two cases of metastatic neuroendocrine tumours stabilised with somatostatin analogues

A role for somatostatin in regulating weight regain after bariatric surgery in mice

Evaluation of somatostatin analogue-JQ1 conjugates for the treatment of pancreatic neuroendocrine tumours

Treatment with (177Lu)-DOTATATE in patients with advanced metastatic somatostatin receptor-positive tumors

Somatostatin analogues effectiveness in non-functioning pituitary adenomas in comparison with acromegaly

Somatostatin analogues treatment did not modify glucose control in acromegalic, diabetic subjects

Interest of a single treatment by somatostatin analogues in a macroadenoma secreting TSH and GH

A somatostatin responsive, ACTH-secreting bronchial carcinoid- a diagnostic and therapeutic challenge

A somatostatin analogue and octreotide exert anti-proliferative effects on colonic cancer cells

Glucose resistance in acromegaly is reversible during somatostatin analogues treatment

Relationship between Insulin and somatostatin secretory response to Glucagon-like peptide-1 (GLP-1) and glucose concentration in perifused rat pancreatic islet cells

Pharmacokinetics of Long Acting Somatostatin Analogue (Lanreotide) Therapy in Hyperinsulinaemic Hypoglycaemia (HH) and Understanding its Molecular Action via Somatostatin Receptors by Immunohistochemistry

The expression and prognostic value of somatostatin and glucagon-like peptide 1 receptors in insulinoma

Effect of treatment with somatostatin analogue on glucose homeostasis in patients with acromegaly

Treatment with (177Lu)-dotatate in patients with advanced metastatic somatostatin receptor-positive tumors

8.15. Metastatic pheochromocytoma and paraganglioma: somatostatin receptor 2 expression, genetics, and therapeutic responses

Predictive factors of somatostatin receptor ligand response in acromegaly  a prospective study

Somatostatin receptors in olfactory neuroblastoma: The rationale for peptide receptor radionuclide therapy

Somatostatin-expressing cells contribute to the pathobiology of atypical congenital hyperinsulinism in infancy

Somatostatin responsive ACTH and precursor excess in a midgut mesentery NET

Acromegaly and Somatostatin Analogues: From Hospital to Home